Targeted Treatment Protocol in Patellofemoral Pain: Does Treatment Designed According to Subgroups Improve Clinical Outcomes in Patients Unresponsive to Multimodal Treatment?
Overview
Authors
Affiliations
Background: Targeted intervention for subgroups is a promising approach for the management of patellofemoral pain.
Hypothesis: Treatment designed according to subgroups will improve clinical outcomes in patients unresponsive to multimodal treatment.
Study Design: Prospective crossover intervention.
Level Of Evidence: Level 3.
Methods: Patients with patellofemoral pain (PFP; n = 61; mean age, 27 ± 9 years) were enrolled. Patients with PFP received standard multimodal treatment 3 times a week for 6 weeks. Patients not responding to multimodal treatment were then classified into 1 of 3 subgroups (strong, weak and tight, and weak and pronated foot) using 6 simple clinical tests. They were subsequently administered 6 further weeks of targeted intervention, designed according to subgroup characteristics. Visual analog scale (VAS), perception of recovery scale (PRS), 5-Level European Quality 5 Dimensions (EQ-5D-5L), and self-reported version of the Leeds Assessment of Neuropathic Symptoms and Signs scale (S-LANSS) were used to assess pain, knee function, and quality of life before and after the interventions.
Results: In total, 34% (n = 21) of patients demonstrated recovery after multimodal treatment. However, over 70% (n = 29/40) of nonresponders demonstrated recovery after targeted treatment. The VAS, PRS, S-LANSS, and EQ-5D-5L scores improved significantly after targeted intervention compared with after multimodal treatment ( < 0.001). The VAS score at rest was significantly lower in the "weak and pronated foot" and the "weak and tight" subgroups ( = 0.011 and = 0.008, respectively). Posttreatment pain intensity on activity was significantly lower in the "strong" subgroup ( = 0.006).
Conclusion: Targeted treatment designed according to subgroup characteristics improves clinical outcomes in patients unresponsive to multimodal treatment.
Clinical Relevance: Targeted intervention could be easily implemented after 6 simple clinical assessment tests to subgroup patients into 1 of 3 subgroups (strong, weak and tight, and weak and pronated foot). Targeted interventions applied according to the characteristics of these subgroups have more beneficial treatment effects than a current multimodal treatment program.
Mertens M, Meeus M, Noten S, Verborgt O, Fransen E, Lluch Girbes E BMJ Open. 2022; 12(11):e056563.
PMID: 36410809 PMC: 9680192. DOI: 10.1136/bmjopen-2021-056563.
Frese C, Bubeck D, Alt W Int J Environ Res Public Health. 2022; 19(16).
PMID: 36011566 PMC: 9408285. DOI: 10.3390/ijerph19169920.
Manojlovic D, Kozinc Z, Sarabon N J Pain Res. 2021; 14:1431-1449.
PMID: 34079359 PMC: 8165213. DOI: 10.2147/JPR.S301448.